new med for type 2 diabetes, Avandia (rosiglitazone)

June 1999

You'll see a new med for type 2 diabetes, Avandia (rosiglitazone).

It's a new "glitazone"...similar to Rezulin (troglitazone). A third one, Actos (pioglitazone) will be out later this summer.

These new drugs come at a good time...with all the concern about hepatotoxicity from Rezulin.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote